LoginSignup
Kuros Bioscience logo

Kuros Bioscience

Stock
Stock
ISIN: CH0325814116
Ticker: KURN
CH0325814116
KURN

Price

Price

CHART BY

Frequently asked questions

What is Kuros Bioscience's market capitalization?

The market capitalization of Kuros Bioscience is $849.06M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Kuros Bioscience?

Kuros Bioscience's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.272. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Kuros Bioscience's stock?

Currently, 1 analysts cover Kuros Bioscience's stock, with a consensus target price of $21.27. Analyst ratings provide insights into the stock's expected performance.

What is Kuros Bioscience's revenue over the trailing twelve months?

Over the trailing twelve months, Kuros Bioscience reported a revenue of $58.82M.

What is the EBITDA for Kuros Bioscience?

Kuros Bioscience's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$2.58M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Kuros Bioscience?

Kuros Bioscience has a free cash flow of -$3.63M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Kuros Bioscience have, and what sector and industry does it belong to?

Kuros Bioscience employs approximately 5 people. It operates in the Health Care sector, specifically within the Biotechnology industry.

What is the free float of Kuros Bioscience's shares?

The free float of Kuros Bioscience is 26.06M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$849.06M
EPS (TTM) 
-$0.272
Free Float 
26.06M
Revenue (TTM) 
$58.82M
EBITDA (TTM) 
-$2.58M
Free Cashflow (TTM) 
-$3.63M

Pricing

1D span
$21.49$22.69
52W span
$3.584$36.13

Analyst Ratings

The price target is $21.27 and the stock is covered by 1 analysts.

Buy

1

Hold

0

Sell

0

Information

Kuros Biosciences Ltd. operates as biopharmaceutical company, which engages in developing products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals, and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment offers Fibrin-PTH, a drug-biologic combination which promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and by increasing the lifespan of bone-forming cells. The Legacy portfolio segment is involved in all other products that do not belong to the group's core business strategy. The company was founded by Didier Cowling in 2000 and is headquartered in Schlieren, Switzerland.

Employees
5
Industries
Biotechnology
Sector
Health Care

Identifier

ISIN
CH0325814116
Primary Ticker
KURN

Knockouts

Join the conversation
Sign upLogin